Published by Josh White on 20th December 2023
(Sharecast News) - Poolbeg Pharma revealed promising results from the lab-based analysis and prioritisation of respiratory syncytial virus (RSV) drug targets and treatments on Wednesday, driven by its artificial intelligence (AI) programme.
URL: http://www.digitallook.com/dl/news/story/33984979/...